Breast Cancer Trial, Recruiting NCT06146231 Sponsor: Establishment Labs Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06146231
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are genetically female and aged 18 or older
  • People who have given written consent to participate in the study
  • People who need tissue expansion as part of breast reconstruction, which may include immediate reconstruction after surgery
  • People whose clinical condition is suitable for this type of breast reconstruction, as determined by the treating doctor
  • People who have enough body fat in donor areas such as the abdomen, buttocks, hips, or thighs, as assessed by the plastic surgeon
  • People who have completed radiotherapy and chemotherapy at least one year before the planned surgery
  • People with a BMI between 18.5 and 30.0
  • People who are physically and mentally able to understand and follow the surgeon's instructions
  • People who are able and willing to attend all required study appointments and follow-up visits

For sub-study participants only:

  • People who give additional consent to have an MRI scan with contrast dye

Who may not be able to join:

  • People who are currently pregnant or breastfeeding, or who become pregnant or breastfeed at any point during the trial
  • People with abnormal blood or biochemical test results following chemotherapy
  • People considered to be at high surgical risk, as determined by the treating doctor
  • People whose breast width is larger than 18 cm
  • People who have remaining tumour in or near the area where tissue expansion is planned
  • People who have metastatic breast cancer (cancer that has spread to other parts of the body)
  • People with significantly drooping breasts or poor skin quality
  • People who do not have enough suitable tissue at the planned expansion site due to previous radiotherapy, skin ulceration, blood vessel involvement, a history of poor wound healing, or scarring from a mastectomy
  • People with insufficient chest wall tissue due to radiation damage, tight skin grafts, or removal of the major chest muscle
  • People with a current or previous infection in the area where expansion is planned
  • People who have a condition that prevents them from having an MRI scan, such as an implanted metal device, claustrophobia, or another relevant medical condition
  • People with autoimmune conditions such as lupus or scleroderma, or people whose immune system is suppressed due to medication
  • People with a known sensitivity to silicone
  • People who are currently smoking
  • People who have previously had a breast reconstruction attempt
  • People considered to be part of a vulnerable population, as determined by the investigator (confirm with trial site)
  • People who are employed by or related to the study sponsor, trial sites, or investigators
  • People who do not live in the same country where the procedure is being performed, making follow-up visits impossible
  • People who are currently participating in another clinical study that may affect the results or follow-up requirements of this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34649713486

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Establishment Labs
Registry
ClinicalTrials.gov
Start date
18 August 2023
Est. completion
1 April 2026

Where this trial is recruiting

🇧🇪 Belgium 🇨🇴 Colombia Costa Rica 🇪🇸 Spain

Primary endpoints

Total adverse envent rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov